The Role of Advanced Glycation End Products in Diabetic Vascular Complications

The Role of Advanced Glycation End Products in Diabetic Vascular Complications

In cases of chronic hyperglycemia, advanced glycation end-products (AGEs) are actively produced and accumulated in the circulating blood and various tissues. AGEs also accelerate the expression of receptors for AGEs, and they play an important role in the development of diabetic vascular complicatio...

Full description

Bibliographic Details
Main Authors:	Sang Youl Rhee, Young Seol Kim
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2018-05-01
Series:	Diabetes & Metabolism Journal
Subjects:	Diabetes complications Glycation end products, advanced Receptor for advanced glycation end products
Online Access:	https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-188.pdf

Similar Items

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
by: Mariyam Khalid, et al.
Published: (2022-04-01)

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
by: Jeongmin Lee, et al.
Published: (2022-07-01)

Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
by: Jing Liu, et al.
Published: (2023-12-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
by: Sarah Louise Fishman, et al.
Published: (2018-11-01)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
by: Tomoka Nakamura, et al.
Published: (2023-06-01)

Association of Novel Advanced Glycation End-Product (AGE10) with Complications of Diabetes as Measured by Enzyme-Linked Immunosorbent Assay
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2021-09-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy
by: Leqaa A. Moemen, et al.
Published: (2020-04-01)

Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
by: Melpomeni Peppa, et al.
Published: (2021-09-01)

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease
by: Li WY, et al.
Published: (2022-10-01)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
by: James N. Tsoporis, et al.
Published: (2020-11-01)

Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes
by: Mattabhorn Phimphilai, et al.
Published: (2021-08-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
by: Ziling Mao, et al.
Published: (2021-12-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus
by: M. M. Kalandiya, et al.
Published: (2023-12-01)

Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review
by: Joana Cortelete Fuhr, et al.
Published: (2022-10-01)

Colorimetric and fluorometric profiling of advanced glycation end products
by: Ammanath, Gopal, et al.
Published: (2022)

A Study on Urinary Glycated Albumin to urinary albumin excretion in gestational diabetes mellitus
by: Chandramallika Paul, et al.
Published: (2021-02-01)

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
by: Cheng YZ, et al.
Published: (2014-11-01)

Inhibition of Advanced Glycation End Products and NADPH Oxidase by <i>Cirsium japonicum</i> in Streptozotocin-Induced Diabetic Rats
by: Jihye Choi, et al.
Published: (2024-03-01)

The role of advanced glycation end products in patogenesis of diabetic nephropathy
by: A. O. Gavrilova, et al.
Published: (2022-01-01)

Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
by: Yu Wing Tong, et al.
Published: (2023-05-01)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
by: Shou-En Wu, et al.
Published: (2021-10-01)

Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension
by: Asparuh Nikolov, et al.
Published: (2020-06-01)

Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products
by: Linzehao Li, et al.
Published: (2022-12-01)